Abstract
Purpose
Endothelial dysfunction is a risk factor for osteonecrosis of femoral head (ONFH) and venous thromboembolism (VTE) [defined as deep venous thrombosis (DVT) or pulmonary embolism (PE)]. However, the risk of unprovoked VTE in non-traumatic ONFH patients remains unclear.
Methods
We investigated the relationship between ONFH and VTE using Taiwan National Health Insurance Research Database (NHIRD). Between 1997 and 2010, a total of 1514 non-traumatic ONFH patients were identified from 1,000,000 general populations after excluding initially concomitant diagnoses of DVT and PE, and subjects undergoing lower limb surgery within one year since enrollment. The comparison group (n = 15,140) without ONFH was set up by matching study cohort with age, gender, income and urbanization in a 1:10 ratio. Subjects diagnosed with VTE within one year after surgery were also excluded.
Results
The patients with non-traumatic ONFH had significantly higher frequency of unprovoked VTE, including DVT, than general population (1.19 vs. 0.5%, p < 0.0007), whereas the frequency of PE was similar between these two groups (p = 0.4922). The cumulative incidence of VTE and DVT was also remarkably higher in the ONFH than non-ONFH group (all p < 0.001). After adjusting for age, gender, medications and comorbidities with multivariate analysis, the ONFH patients had a 2.3-fold increase in risk of DVT compared with non-ONFH counterparts (95% CI 1.28 to 4.13, p = 0.0053). Apart from ONFH, age > 65 years and hypertension were also identified as risk factors for DVT occurrence.
Conclusions
The incidence and risk of unprovoked VTE were significantly increased in the non-traumatic ONFH population.
Similar content being viewed by others
Abbreviations
- AVN:
-
Avascular necrosis
- ONFH:
-
Osteonecrosis of femoral head
- NO:
-
Nitic oxide
- VTE:
-
Venous thromboembolic events
- DVT:
-
Deep vein thrombosis
- PE:
-
Pulmonary embolism
- NHIRD:
-
National Health Insurance Research Database
- NHRI:
-
National Health Research Institute
- RAAS:
-
Renin-angiotensin-aldosterone system
References
DiGiovanni CW, Patel A, Calfee R et al (2007) Osteonecrosis in the foot. J Am Acad Orthop Surg 15:208–217
Lafforgue P (2006) Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine 73:500–507. https://doi.org/10.1016/j.jbspin.2006.01.025
Mont MA, Hungerford DS (1995) Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 77:459–474
Agarwala S, Jain D, Joshi VR et al (2005) Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology 44:352–359. https://doi.org/10.1093/rheumatology/keh481
Wang CJ, Wang FS, Huang CC et al (2005) Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am 87:2380–2387. https://doi.org/10.2106/jbjs.e.00174
Gangji V, Hauzeur J-P (2005) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. J Bone Joint Surg Am:106–112
Lieberman JR, Conduah A, Urist MR (2004) Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res:139–145
Myers TG, Cui Q, Kuskowski M et al (2006) Outcomes of total and unicompartmental knee arthroplasty for secondary and spontaneous osteonecrosis of the knee. J Bone Joint Surg Am 88(Suppl 3):76–82. https://doi.org/10.2106/jbjs.f.00568
Woo SB, Hellstein JW, Kalmar JR (2006) Systemic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753–761
Chao YC, Wang SJ, Chu HC et al (2003) Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. Alcohol Alcohol 38:431–436
Juery P (2007) Avascular necrosis after a steroid injection. CMAJ 176:814. https://doi.org/10.1503/cmaj.1060165
Mankin HJ (1992) Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 326:1473–1479. https://doi.org/10.1056/nejm199205283262206
Chang CC, Greenspan A, Gershwin ME (1993) Osteonecrosis: current perspectives on pathogenesis and treatment. Semin Arthritis Rheum 23:47–69
Chim SM, Tickner J, Chow ST et al (2013) Angiogenic factors in bone local environment. Cytokine Growth Factor Rev 24:297–310. https://doi.org/10.1016/j.cytogfr.2013.03.008
Kerachian MA, Harvey EJ, Cournoyer D et al (2006) Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13:237–244. https://doi.org/10.1080/10623320600904211
Camporesi EM, Vezzani G, Bosco G et al (2010) Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplast 25:118–123. https://doi.org/10.1016/j.arth.2010.05.005
Wolberg AS, Rosendaal FR, Weitz JI et al (2015) Venous thrombosis. Nat Rev Dis Primers 1:15006. https://doi.org/10.1038/nrdp.2015.6
Hill JM, Zalos G, Halcox JP et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600. https://doi.org/10.1056/NEJMoa022287
Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction testing and clinical relevance. Circulation 115:1285–1295
Marti CN, Gheorghiade M, Kalogeropoulos AP et al (2012) Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 60:1455–1469. https://doi.org/10.1016/j.jacc.2011.11.082
Gresele P, Momi S, Migliacci R (2010) Endothelium, venous thromboembolism and ischaemic cardiovascular events. Thromb Haemost 103:56–61. https://doi.org/10.1160/th09-08-0562
Migliacci R, Becattini C, Pesavento R et al (2007) Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica 92:812–818
Cheng T-M (2009) Taiwan’s National Health Insurance system: high value for the dollar. In: Okma KGH, Crivelli L (eds) Six countries, six reform models: the health reform experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan. World Scientific, New Jersey, pp 71–204
(2010) Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. National Clinical Guideline Centre-Acute and Chronic Conditions., London
Rackwitz L, Eden L, Reppenhagen S et al (2012) Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Res Ther 3:7. https://doi.org/10.1186/scrt98
(2012) Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. National Clinical Guideline Centre., London
Ceriello A, Quagliaro L, Piconi L et al (2004) Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53:701–710
Brotman DJ, Deitcher SR, Lip GY et al (2004) Virchow’s triad revisited. South Med J 97:213–214. https://doi.org/10.1097/01.smj.0000105663.01648.25
Luo RB, Lin T, Zhong HM et al (2014) Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review. Med Sci Monit 20:2439–2447. https://doi.org/10.12659/msm.891123
Gao F, Sun W, Li Z et al (2015) High-energy extracorporeal shock wave for early stage osteonecrosis of the femoral head: a single-center case series. Evid Based Complement Alternat Med 2015:468090. https://doi.org/10.1155/2015/468090
Wang CJ, Cheng JH, Huang CC et al (2015) Extracorporeal shockwave therapy for avascular necrosis of femoral head. Int J Surg 24:184–187. https://doi.org/10.1016/j.ijsu.2015.06.080
Wassmann S, Laufs U, Baumer AT et al (2001) HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 37:1450–1457
Ceriello A, Assaloni R, Da Ros R et al (2005) Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 111:2518–2524. https://doi.org/10.1161/01.cir.0000165070.46111.9f
Ferrario CM, Strawn WB (2006) Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98:121–128. https://doi.org/10.1016/j.amjcard.2006.01.059
Fowkes FJ, Price JF, Fowkes FG (2003) Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 25:1–5
Silverstein MD, Heit JA, Mohr DN et al (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585–593
Schmidt M, Christiansen CF, Horvath-Puho E et al (2011) Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism. J Thromb Haemost 9:1326–1333. https://doi.org/10.1111/j.1538-7836.2011.04354.x
Ungprasert P, Srivali N, Wijarnpreecha K et al (2015) Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis. Rheumatology 54:736–742. https://doi.org/10.1093/rheumatology/keu408
Johannesdottir SA, Horvath-Puho E, Dekkers OM et al (2013) Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 173:743–752. https://doi.org/10.1001/jamainternmed.2013.122
Barritt DW, Jordan SC (1960) Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1:1309–1312
Konstantinides SV, Torbicki A, Agnelli G, et al. (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35:3033-3069, 3069a-3069k. https://doi.org/10.1093/eurheartj/ehu283
Acknowledgements
We would like to thank Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, Taiwan for data acquisition. We also thank Health Information and Epidemiology Laboratory of Chang Gung Memorial Hospital, Chia-yi Branch, Taiwan (CLRPG6G0041) for the comments and assistance in data analysis. In addition, this study was supported by a grant from Chia-yi Chang Gung Memorial Hospital, and based on the National Health Insurance Research Database offered by the Bureau of National Health Insurance, Department of Health, Taiwan. We analyzed and interpreted the retrieved data for academic purpose, and therefore the viewpoint is not represented by the Bureau of National Health Insurance, Department of Health, or National Health Research Institutes.
Author information
Authors and Affiliations
Contributions
P.H.S and H.J.C. participated in the design of the study, data acquisition, and analysis as well as drafting the manuscript. Y.H.Y and C.J.C. were responsible for the data acquisition and troubleshooting. J.Y.C. and H.K.Y. participated in data analysis, and interpretation. M.S.L. conceived of the study, participated in its design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
This article is the sole work of the authors. All authors report no conflict of interest.
Ethical review committee statement
This study was approved by the Ethics Institutional Review Board of Chang Gung Memorial Hospital (No. 201600738B1).
Rights and permissions
About this article
Cite this article
Sung, PH., Chiang, HJ., Yang, YH. et al. Nationwide study on the risk of unprovoked venous thromboembolism in non-traumatic osteonecrosis of femoral head. International Orthopaedics (SICOT) 42, 1469–1478 (2018). https://doi.org/10.1007/s00264-018-3866-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-018-3866-2